Evidence map›Paper›PMID 33879049›Full record

ArticleBMC microbiology2021

Treatment with surfactants enables quantification of translational activity by O-propargyl-puromycin labelling in yeast.

Jennifer Staudacher, Corinna Rebnegger, Brigitte Gasser

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jennifer StaudacherChristian Doppler Laboratory for Growth-decoupled Protein Production in Yeast, Department of Biotechnology, BOKU University of Natural Resources and Life Sciences, Vienna, Austria.
Corinna RebneggerChristian Doppler Laboratory for Growth-decoupled Protein Production in Yeast, Department of Biotechnology, BOKU University of Natural Resources and Life Sciences, Vienna, Austria.
Brigitte GasserChristian Doppler Laboratory for Growth-decoupled Protein Production in Yeast, Department of Biotechnology, BOKU University of Natural Resources and Life Sciences, Vienna, Austria. brigitte.gasser@boku.ac.at.ORCID 0000-0003-2881-6370
BOKU University · ATChristian Doppler Laboratory for Thermoelectricity · AT

Funding

Bundesministerium für Digitalisierung und Wirtschaftsstandort CD-PichiaChristian Doppler Forschungsgesellschaft CD-PichiaÖsterreichische Nationalstiftung für Forschung, Technologie und Entwicklung CD-Pichia
6 · The paper itself

Abstract

backgroundTranslation is an important point of regulation in protein synthesis. However, there is a limited number of methods available to measure global translation activity in yeast. Recently, O-propargyl-puromycin (OPP) labelling has been established for mammalian cells, but unmodified yeasts are unsusceptible to puromycin.

resultsWe could increase susceptibility by using a Komagataella phaffii strain with an impaired ergosterol pathway (erg6Δ), but translation measurements are restricted to this strain background, which displayed growth deficits. Using surfactants, specifically Imipramine, instead, proved to be more advantageous and circumvents previous restrictions. Imipramine-supplemented OPP-labelling with subsequent flow cytometry analysis, enabled us to distinguish actively translating cells from negative controls, and to clearly quantify differences in translation activities in different strains and growth conditions. Specifically, we investigated K. phaffii at different growth rates, verified that methanol feeding alters translation activity, and analysed global translation in strains with genetically modified stress response pathways.

conclusionsWe set up a simple protocol to measure global translation activity in yeast on a single cell basis. The use of surfactants poses a practical and non-invasive alternative to the commonly used ergosterol pathway impaired strains and thus impacts a wide range of applications where increased drug and dye uptake is needed.

Indexed as

ImipramineProtein BiosynthesisPuromycinSaccharomycetalesSurface-Active AgentsImipramineO-propargyl-puromycinPuromycinSurface-Active AgentsGlobal translation activityKomagataella phaffii (Pichia pastoris)O-propargyl-puromycin (OPP)Stress responseSurfactant

Identifiers

PMID33879049
PMCPMC8056590
OpenAlexW3155637808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.